Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Oral Dose Study of SGM-1019 in Healthy Subjects

Next Previous
Trial Profile

A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Oral Dose Study of SGM-1019 in Healthy Subjects

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 12 Apr 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SGM 1019 (Primary)
  • Indications Inflammatory bowel diseases
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Second Genome

    • Most Recent Events

    • 09 Apr 2018 Results (safety and pharmacodynamics) presented in a Second Genome media release.
    • 09 Apr 2018 According to a Second Genome media release, preclinical data and results from this trial will be presented at the European Association for the Study of the Liver (EASL) International Liver Congress 2018 (on Friday, 13 Apr 2018).
    • 20 Jan 2015 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top